Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

How will increasing our knowledge of the head and neck cancer cells' secretome benefit head and neck squamous cell carcinoma patients?

Ralhan R.

Expert Rev Proteomics. 2012 Apr;9(2):115-8. doi: 10.1586/epr.12.1. No abstract available.

PMID:
22462781
2.

Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.

Ralhan R, Masui O, Desouza LV, Matta A, Macha M, Siu KW.

Proteomics. 2011 Jun;11(12):2363-76. doi: 10.1002/pmic.201000186. Epub 2011 May 20.

PMID:
21598386
3.

Personalizing cancer care: updates on head and neck cancer.

de Souza JA, Cohen EE.

Expert Rev Anticancer Ther. 2009 Sep;9(9):1219-22. doi: 10.1586/era.09.101.

PMID:
19761425
4.
5.

SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.

Eibling DE, Johnson JT, Wagner RL, Su S.

Laryngoscope. 1989 Feb;99(2):117-24.

PMID:
2913421
6.
7.

Cervical lymphatics and squamous cell carcinoma of the head and neck: biologic significance and therapeutic considerations.

Carlson GW.

Surg Oncol Clin N Am. 1996 Jan;5(1):65-77. Review. No abstract available.

PMID:
8789494
8.

Pathobiology of head and neck squamous tumorigenesis.

El-Naggar AK.

Curr Cancer Drug Targets. 2007 Nov;7(7):606-12. Review.

PMID:
18045065
9.

Can molecular markers predict local, regional and distant metastasis in head and neck cancer?

Haffty BG.

Nat Clin Pract Oncol. 2005 Mar;2(3):132-3. No abstract available.

PMID:
16264904
10.

Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis.

Fischer CA, Jung M, Zlobec I, Green E, Storck C, Tornillo L, Lugli A, Wolfensberger M, Terracciano LM.

Head Neck. 2011 Feb;33(2):267-73. doi: 10.1002/hed.21440.

PMID:
20848449
11.
12.

Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients.

Wong MP, Cheang M, Yorida E, Coldman A, Gilks CB, Huntsman D, Berean K.

Pathology. 2008 Oct;40(6):611-6. doi: 10.1080/00313020802320614.

PMID:
18752129
13.

Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.

Marimuthu A, Chavan S, Sathe G, Sahasrabuddhe NA, Srikanth SM, Renuse S, Ahmad S, Radhakrishnan A, Barbhuiya MA, Kumar RV, Harsha HC, Sidransky D, Califano J, Pandey A, Chatterjee A.

Biochim Biophys Acta. 2013 Nov;1834(11):2308-16. doi: 10.1016/j.bbapap.2013.04.029. Epub 2013 May 7.

PMID:
23665456
14.

Prognostic markers in cancers of the head and neck region.

Kearsley JH, Thomas S.

Anticancer Drugs. 1993 Aug;4(4):419-29. Review.

PMID:
8400343
15.

Clinical experiences in managing head and neck squamous carcinoma.

Berger W, Goldstein J, Strawberry C.

Ear Nose Throat J. 1984 Dec;63(12):591-6. No abstract available.

PMID:
6510309
16.

Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.

Singh B, Stoffel A, Gogineni S, Poluri A, Pfister DG, Shaha AR, Pathak A, Bosl G, Cordon-Cardo C, Shah JP, Rao PH.

Am J Pathol. 2002 Aug;161(2):365-71.

17.

Head and neck squamous cell carcinoma targeted chemosensitization.

Figures MR, Wobb J, Araki K, Liu T, Xu L, Zhu H, O'Malley BW Jr, Li D.

Otolaryngol Head Neck Surg. 2009 Aug;141(2):177-83. doi: 10.1016/j.otohns.2009.04.024.

PMID:
19643248
18.

Role of molecular markers in the management of head and neck cancers.

Ferreira MB, De Souza JA, Cohen EE.

Curr Opin Oncol. 2011 May;23(3):259-64. doi: 10.1097/CCO.0b013e328344f53a. Review.

PMID:
21358329
19.

Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma.

Goumas PD, Mastronikolis NS, Mastorakou AN, Vassilakos PJ, Nikiforidis GC.

ORL J Otorhinolaryngol Relat Spec. 1997 Mar-Apr;59(2):106-14.

PMID:
9166881
20.

Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis.

Ruokolainen H, Pääkkö P, Turpeenniemi-Hujanen T.

Clin Cancer Res. 2004 May 1;10(9):3110-6.

Supplemental Content

Support Center